Synergizing radiation therapy and immunotherapy for curing incurable cancers: Opportunities and challenges

James W. Hodge, Chandan Guha, Jacques Neefjes, James L. Gulley

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The combination of radiation therapy and immunotherapy holds particular promise as a strategy for cancer therapeutics. Evidence suggests that immunotherapy is most beneficial alone when employed early in the disease process or in combination with standard therapies (eg, radiation) later in the disease process. Indeed, radiation may act synergistically with immunotherapy to enhance immune responses, inhibit immunosuppression, and/or alter the phenotype of tumor cells, thus rendering them more susceptible to immune-mediated killing. As monotherapies, both immunotherapy and radiation may be insufficient to eliminate tumor masses. However, following immunization with a cancer vaccine, the destruction of even a small percentage of tumor cells by radiation could result in crosspriming and presentation of tumor antigens to the immune system, thereby potentiating antitumor responses. Learning how to exploit radiation-induced changes to tumor-cell antigens, and how to induce effective immune responses to these cumulatively immunogenic stimuli, is an exciting frontier in cancer therapy research. This review examines mechanisms by which many forms of radiation therapy can induce or augment antitumor immune responses as well as preclinical systems demonstrating that immunotherapy can be effectively combined with radiation therapy. Finally, we review current clinical trials where standard-of-care radiation therapy is being combined with immunotherapy.

Original languageEnglish (US)
Pages (from-to)1064-1070
Number of pages7
JournalOncology
Volume22
Issue number9
StatePublished - Aug 2008

Fingerprint

Immunotherapy
Radiotherapy
Radiation
Neoplasms
Neoplasm Antigens
Cancer Vaccines
Standard of Care
Immunosuppression
Immune System
Immunization
Clinical Trials
Learning
Phenotype
Therapeutics
Research

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Synergizing radiation therapy and immunotherapy for curing incurable cancers : Opportunities and challenges. / Hodge, James W.; Guha, Chandan; Neefjes, Jacques; Gulley, James L.

In: Oncology, Vol. 22, No. 9, 08.2008, p. 1064-1070.

Research output: Contribution to journalArticle

Hodge, James W. ; Guha, Chandan ; Neefjes, Jacques ; Gulley, James L. / Synergizing radiation therapy and immunotherapy for curing incurable cancers : Opportunities and challenges. In: Oncology. 2008 ; Vol. 22, No. 9. pp. 1064-1070.
@article{9e81afe0530e43569720c09801f2849d,
title = "Synergizing radiation therapy and immunotherapy for curing incurable cancers: Opportunities and challenges",
abstract = "The combination of radiation therapy and immunotherapy holds particular promise as a strategy for cancer therapeutics. Evidence suggests that immunotherapy is most beneficial alone when employed early in the disease process or in combination with standard therapies (eg, radiation) later in the disease process. Indeed, radiation may act synergistically with immunotherapy to enhance immune responses, inhibit immunosuppression, and/or alter the phenotype of tumor cells, thus rendering them more susceptible to immune-mediated killing. As monotherapies, both immunotherapy and radiation may be insufficient to eliminate tumor masses. However, following immunization with a cancer vaccine, the destruction of even a small percentage of tumor cells by radiation could result in crosspriming and presentation of tumor antigens to the immune system, thereby potentiating antitumor responses. Learning how to exploit radiation-induced changes to tumor-cell antigens, and how to induce effective immune responses to these cumulatively immunogenic stimuli, is an exciting frontier in cancer therapy research. This review examines mechanisms by which many forms of radiation therapy can induce or augment antitumor immune responses as well as preclinical systems demonstrating that immunotherapy can be effectively combined with radiation therapy. Finally, we review current clinical trials where standard-of-care radiation therapy is being combined with immunotherapy.",
author = "Hodge, {James W.} and Chandan Guha and Jacques Neefjes and Gulley, {James L.}",
year = "2008",
month = "8",
language = "English (US)",
volume = "22",
pages = "1064--1070",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "9",

}

TY - JOUR

T1 - Synergizing radiation therapy and immunotherapy for curing incurable cancers

T2 - Opportunities and challenges

AU - Hodge, James W.

AU - Guha, Chandan

AU - Neefjes, Jacques

AU - Gulley, James L.

PY - 2008/8

Y1 - 2008/8

N2 - The combination of radiation therapy and immunotherapy holds particular promise as a strategy for cancer therapeutics. Evidence suggests that immunotherapy is most beneficial alone when employed early in the disease process or in combination with standard therapies (eg, radiation) later in the disease process. Indeed, radiation may act synergistically with immunotherapy to enhance immune responses, inhibit immunosuppression, and/or alter the phenotype of tumor cells, thus rendering them more susceptible to immune-mediated killing. As monotherapies, both immunotherapy and radiation may be insufficient to eliminate tumor masses. However, following immunization with a cancer vaccine, the destruction of even a small percentage of tumor cells by radiation could result in crosspriming and presentation of tumor antigens to the immune system, thereby potentiating antitumor responses. Learning how to exploit radiation-induced changes to tumor-cell antigens, and how to induce effective immune responses to these cumulatively immunogenic stimuli, is an exciting frontier in cancer therapy research. This review examines mechanisms by which many forms of radiation therapy can induce or augment antitumor immune responses as well as preclinical systems demonstrating that immunotherapy can be effectively combined with radiation therapy. Finally, we review current clinical trials where standard-of-care radiation therapy is being combined with immunotherapy.

AB - The combination of radiation therapy and immunotherapy holds particular promise as a strategy for cancer therapeutics. Evidence suggests that immunotherapy is most beneficial alone when employed early in the disease process or in combination with standard therapies (eg, radiation) later in the disease process. Indeed, radiation may act synergistically with immunotherapy to enhance immune responses, inhibit immunosuppression, and/or alter the phenotype of tumor cells, thus rendering them more susceptible to immune-mediated killing. As monotherapies, both immunotherapy and radiation may be insufficient to eliminate tumor masses. However, following immunization with a cancer vaccine, the destruction of even a small percentage of tumor cells by radiation could result in crosspriming and presentation of tumor antigens to the immune system, thereby potentiating antitumor responses. Learning how to exploit radiation-induced changes to tumor-cell antigens, and how to induce effective immune responses to these cumulatively immunogenic stimuli, is an exciting frontier in cancer therapy research. This review examines mechanisms by which many forms of radiation therapy can induce or augment antitumor immune responses as well as preclinical systems demonstrating that immunotherapy can be effectively combined with radiation therapy. Finally, we review current clinical trials where standard-of-care radiation therapy is being combined with immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=52649153457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52649153457&partnerID=8YFLogxK

M3 - Article

C2 - 18777956

AN - SCOPUS:52649153457

VL - 22

SP - 1064

EP - 1070

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 9

ER -